quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:18:25·1021d
NEWSRelease
BELLUS Health Inc. logo
GSK plc logo
IVERIC bio Inc. logo
+2

From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs

BLU· BELLUS Health Inc.GSK· GSK plcISEE· IVERIC bio Inc.PFE· Pfizer Inc.SGEN· Seagen Inc.
Health Care
Original source

Companies

  • BLU
    BELLUS Health Inc.
    Health Care
  • GSK
    GSK plc
    Health Care
  • ISEE
    IVERIC bio Inc.
    Health Care
  • PFE
    Pfizer Inc.
    Health Care
  • SGEN
    Seagen Inc.
    Health Care

Recent analyst ratings

  • Mar 2PFEUpdateArgus$35.00
  • Feb 25PFEUpdateRBC Capital Mkts$25.00
  • Feb 20PFEUpdateBarclays$25.00
  • Feb 12PFEUpdateDaiwa Securities$27.00
  • Jan 27GSKUpdateCitigroup-
  • Jan 7PFEUpdateUBS$25.00

Related

  • PR29m
    Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
  • SEC1d
    SEC Form 6-K filed by GSK plc
  • PR1d
    Pfizer Declares Second-Quarter 2026 Dividend
  • SEC2d
    SEC Form 6-K filed by GSK plc
  • PR2d
    Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
  • SEC3d
    SEC Form 6-K filed by GSK plc
  • SEC3d
    SEC Form 6-K filed by GSK plc
  • PR4d
    U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022